Literature DB >> 21932398

Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.

Elaine Studer1, Xiqiao Zhou, Renping Zhao, Yun Wang, Kazuaki Takabe, Masayuki Nagahashi, William M Pandak, Paul Dent, Sarah Spiegel, Ruihua Shi, Weiren Xu, Xuyuan Liu, Pat Bohdan, Luyong Zhang, Huiping Zhou, Phillip B Hylemon.   

Abstract

Bile acids have been shown to be important regulatory molecules for cells in the liver and gastrointestinal tract. They can activate various cell signaling pathways including extracellular regulated kinase (ERK)1/2 and protein kinase B (AKT) as well as the G-protein-coupled receptor (GPCR) membrane-type bile acid receptor (TGR5/M-BAR). Activation of the ERK1/2 and AKT signaling pathways by conjugated bile acids has been reported to be sensitive to pertussis toxin (PTX) and dominant-negative Gα(i) in primary rodent hepatocytes. However, the GPCRs responsible for activation of these pathways have not been identified. Screening GPCRs in the lipid-activated phylogenetic family (expressed in HEK293 cells) identified sphingosine-1-phosphate receptor 2 (S1P(2) ) as being activated by taurocholate (TCA). TCA, taurodeoxycholic acid (TDCA), tauroursodeoxycholic acid (TUDCA), glycocholic acid (GCA), glycodeoxycholic acid (GDCA), and S1P-induced activation of ERK1/2 and AKT were significantly inhibited by JTE-013, a S1P(2) antagonist, in primary rat hepatocytes. JTE-013 significantly inhibited hepatic ERK1/2 and AKT activation as well as short heterodimeric partner (SHP) mRNA induction by TCA in the chronic bile fistula rat. Knockdown of the expression of S1P(2) by a recombinant lentivirus encoding S1P(2) shRNA markedly inhibited the activation of ERK1/2 and AKT by TCA and S1P in rat primary hepatocytes. Primary hepatocytes prepared from S1P(2) knock out (S1P(2) (-/-) ) mice were significantly blunted in the activation of the ERK1/2 and AKT pathways by TCA. Structural modeling of the S1P receptors indicated that only S1P(2) can accommodate TCA binding. In summary, all these data support the hypothesis that conjugated bile acids activate the ERK1/2 and AKT signaling pathways primarily through S1P(2) in primary rodent hepatocytes.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21932398      PMCID: PMC3245352          DOI: 10.1002/hep.24681

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

Review 1.  Structural features of EDG1 receptor-ligand complexes revealed by computational modeling and mutagenesis.

Authors:  A L Parrill; D L Baker; D A Wang; D J Fischer; D L Bautista; J Van Brocklyn; S Spiegel; G Tigyi
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

2.  Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate.

Authors:  A L Parrill; D Wang; D L Bautista; J R Van Brocklyn; Z Lorincz; D J Fischer; D L Baker; K Liliom; S Spiegel; G Tigyi
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

3.  The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice.

Authors:  Yan-Dong Wang; Wei-Dong Chen; Donna Yu; Barry M Forman; Wendong Huang
Journal:  Hepatology       Date:  2011-08-11       Impact factor: 17.425

Review 4.  Extracellular and intracellular actions of sphingosine-1-phosphate.

Authors:  Graham M Strub; Michael Maceyka; Nitai C Hait; Sheldon Milstien; Sarah Spiegel
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 5.  LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.

Authors:  Kotaro Hama; Junken Aoki
Journal:  Prog Lipid Res       Date:  2010-03-15       Impact factor: 16.195

Review 6.  Targeting orphan nuclear receptor SHP in the treatment of metabolic diseases.

Authors:  Mi-Kyung Kim; Dipanjan Chanda; In-Kyu Lee; Hueng-Sik Choi; Keun-Gyu Park
Journal:  Expert Opin Ther Targets       Date:  2010-04       Impact factor: 6.902

7.  Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway.

Authors:  Dong Fu; Yoshiyuki Wakabayashi; Jennifer Lippincott-Schwartz; Irwin M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

8.  Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells.

Authors:  Toshiyuki Imasawa; Kentaro Koike; Isao Ishii; Jerold Chun; Yutaka Yatomi
Journal:  Biochem Biophys Res Commun       Date:  2010-01-12       Impact factor: 3.575

9.  Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via G(alpha)i-protein-coupled receptors and the AKT pathway.

Authors:  Risheng Cao; Zhumei Xu Cronk; Weibin Zha; Lixin Sun; Xuan Wang; Youwen Fang; Elaine Studer; Huiping Zhou; William M Pandak; Paul Dent; Gregorio Gil; Phillip B Hylemon
Journal:  J Lipid Res       Date:  2010-03-20       Impact factor: 5.922

10.  Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation.

Authors:  Sang Won Park; Mihwa Kim; Sean W C Chen; Kevin M Brown; Vivette D D'Agati; H Thomas Lee
Journal:  Lab Invest       Date:  2010-05-10       Impact factor: 5.662

View more
  103 in total

1.  Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression.

Authors:  Masayuki Nagahashi; Kazuaki Takabe; Runping Liu; Kesong Peng; Xiang Wang; Yun Wang; Nitai C Hait; Xuan Wang; Jeremy C Allegood; Akimitsu Yamada; Tomoyoshi Aoyagi; Jie Liang; William M Pandak; Sarah Spiegel; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

2.  eNOS deletion impairs mitochondrial quality control and exacerbates Western diet-induced NASH.

Authors:  Ryan D Sheldon; Grace M Meers; E Matthew Morris; Melissa A Linden; Rory P Cunningham; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-30       Impact factor: 4.310

Review 3.  Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis.

Authors:  Yifeng Wang; Wen-Xing Ding; Tiangang Li
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-10       Impact factor: 4.698

Review 4.  Microbial modulation of cardiovascular disease.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Nat Rev Microbiol       Date:  2018-01-08       Impact factor: 60.633

5.  Bile Acid Receptors and Gastrointestinal Functions.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Liver Res       Date:  2019-01-14

Review 6.  The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Monica D Chow; Yi-Horng Lee; Grace L Guo
Journal:  Mol Aspects Med       Date:  2017-05-05

Review 7.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 8.  Bile acids are nutrient signaling hormones.

Authors:  Huiping Zhou; Phillip B Hylemon
Journal:  Steroids       Date:  2014-05-10       Impact factor: 2.668

Review 9.  Effects of bile acids on neurological function and disease.

Authors:  Matthew McMillin; Sharon DeMorrow
Journal:  FASEB J       Date:  2016-07-28       Impact factor: 5.191

Review 10.  The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.

Authors:  Masayuki Nagahashi; Kizuki Yuza; Yuki Hirose; Masato Nakajima; Rajesh Ramanathan; Nitai C Hait; Phillip B Hylemon; Huiping Zhou; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Lipid Res       Date:  2016-07-26       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.